Related Experiment Video
Updated: Jul 6, 2026

Profiling of Estrogen-regulated MicroRNAs in Breast Cancer Cells
Published on: February 21, 2014
Estrogen receptors and cell proliferation in breast cancer
1Laboratory of Reproduction and Lactation (LARLAC), Regional Center for Scientific and Technological Research (CRICYT), Mendoza 5500, Argentina.
Abstract:
Most of the actions of estrogens on the normal and abnormal mammary cells are mediated via estrogen receptors (ERs), including control of cell proliferation; however, there are also alternative pathways of estrogen action not involving ERs. Estrogens control several genes and proteins that induce the cells to enter the cell cycle (protooncogenes, growth factors); estrogens also act on proteins directly involved in the control of the cell cycle (cyclins), and moreover, estrogens stimulate the response of negative cell cycle regulators (p53, BRCA1). The next challenge for researchers is elucidating the integration of the interrelationships of the complex pathways involved in the control of cell proliferation. This brief review focuses on the mechanisms of estrogen action to control cell proliferation and the clinical implications in breast cancer. (Trends Endocrinol Metab 1997;8:313-321). (c) 1997, Elsevier Science Inc.
Insights
Estrogen receptors (ERs) mediate many estrogen effects on mammary cells, controlling proliferation via cell cycle pathways. Further research is needed to understand these complex interactions and their clinical implications in breast cancer.
Area of Science:
- Endocrinology
- Cell Biology
- Oncology
Background:
- Estrogen's role in mammary cell proliferation is primarily mediated by estrogen receptors (ERs).
- Alternative, non-ER pathways also contribute to estrogen's effects on mammary cells.
- Estrogens influence key regulators of the cell cycle, including protooncogenes, growth factors, cyclins, p53, and BRCA1.
Purpose of the Study:
- To review the mechanisms of estrogen action on cell proliferation.
- To discuss the clinical implications of these mechanisms in breast cancer.
Main Methods:
- Literature review of studies on estrogen action in mammary cells.
- Focus on pathways involving estrogen receptors (ERs) and non-ER pathways.
- Analysis of estrogen's effects on cell cycle regulators.
Main Results:
- Estrogens, via ERs and other pathways, regulate genes and proteins controlling cell cycle entry and progression.
- Estrogens impact both positive regulators (protooncogenes, cyclins) and negative regulators (p53, BRCA1) of the cell cycle.
- Understanding these complex interactions is crucial for breast cancer research.
Conclusions:
- Estrogen's control of mammary cell proliferation involves intricate ER-dependent and ER-independent pathways.
- Elucidating the integration of these pathways is a key challenge for future research.
- These mechanisms have significant clinical implications for breast cancer treatment and management.
Related Concept Videos
Mitogens and the Cell Cycle
Transducer Mechanism: Nuclear Receptors
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Target Cell Response to Hormones
Notably, the cellular response can be regulated by altering the number of receptors expressed in the cell. For example, prolonged exposure to elevated hormone levels results in a gradual decline or down-regulation in the number of receptors for that specific hormone on the cell surface. Conversely, in response to low hormone levels, cells may use up-regulation, producing an...
Abnormal Proliferation
